EGFR Tyrosine Kinase Inhibitor therapy in progressive lung cancer patient
Illustration by Sehatku.com
Tyrosine kinase inhibitor (TKI) has been widely used as a cancer therapy for patients who have EGFR mutations. However, patients who have EGFR mutations only benefit from EGFR-TKI therapy for…